Transcription factor Spl expression in gastric cancer and its prognostic value

Objective To investigate the expression of transcription factor Sp1 in human gastric cancer tissues and normal gastric mucosa, and its prognostic significance. Methods By using immunohistochemistry, we studied the Sp1 expression patterns in 65 cases of gastric cancer with various clinico-pathologic characteristics, and 40 normal gastric mucosa specimens obtained from patients who underwent partial gastreetomy for benign gastric diseases. The significance of Sp1 expression on the survival of patients was evaluated. Results The expression rate of Sp1 in normal gastric mueosa was 12.5% （5/ 40）. The positively stained glandular cells were mainly limited to those in the neck region. Cells at the basal portion of the gland were essentially negative. In sharp contrast, Sp1 expression rate in gastric cancer lesions was 53.8% （35/65）. The medium survival time in patients who had a tumor with negative, weak and strong Sp1 expression was 1700, 1560 and 1026 days, respectively （P = 0. 036）. Sp1 protein expression was closely related to the depth of tumor invasion and TNM stage （ P = 0. 001, P = 0. 026 ） , but not related to the number of metastatic lymph nodes and Lauren＇s classification （ P = 0.306 , P = 0.667 ） . Conclusion Normal and malignant gastric tissues have unique Sp1 expression patterns. Sp1 might be served as an independent prognostic factor. Key words: Transcription factor Sp1 ;  Stomach neoplasms ;  Prognosis